Recruiting
Phase 2

Delivery of Inhibitors of Lysyl Oxidase (LysoLox) on Serial Angioplasty and Time to Restenosis

Sponsor:

Southeast Renal Research Institute

Code:

NCT03106948

Conditions

Arteriovenous Fistula Occlusion

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Placebo

Ascorbic Acid

Cuprimine Oral Product

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information